Ticker Details
AN2 Therapeutics, Inc.
IPO Date:	March 25, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$28.5M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 4.11%
Avg Daily Range (30 D):	$0.03 | 2.89%
Avg Daily Range (90 D):	$0.04 | 3.08%

Institutional Daily Volume
Avg Daily Volume:	.16M
Avg Daily Volume (30 D):	.07M
Avg Daily Volume (90 D):	.08M

Trade Size
Avg Trade Size (Sh.):	192
Avg Trade Size (Sh.) (30 D):	274
Avg Trade Size (Sh.) (90 D):	299

Institutional Trades
Total Institutional Trades:	54
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$.79M
Avg Institutional Trade (90 D):	$.79M
Avg Institutional Trade Volume:	.4M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.45M
Avg Closing Trade (30 D):	$.54M
Avg Closing Trade (90 D):	$.54M
Avg Closing Volume:	225.92K

News

May 21, 2024 @ 1:35 PM Down -5.51% in 4 Weeks, Here's Why AN2 Therapeutic... Source: Zacks Equity Research

Feb 13, 2024 @ 1:08 PM ZoomInfo Technologies To Rally Around 50%? Here Ar... Source: Avi Kapoor

Feb 12, 2024 @ 7:15 PM Nasdaq Edges Lower; ContextLogic Shares Surge Source: Avi Kapoor

Feb 12, 2024 @ 6:07 PM Why Big Lots Shares Are Trading Lower By Around 31... Source: Avi Kapoor

Feb 12, 2024 @ 5:30 PM Dow Surges Over 150 Points; Gilead Sciences To Acq... Source: Avi Kapoor

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.13	$-.31	$-.21
Diluted EPS	$-1.13	$-.31	$-.21
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-33.99M	$-9.35M	$-6.46M
Operating Income / Loss	$-37.39M	$-10.04M	$-7.22M
Cost of Revenue
Net Cash Flow	$-15.5M	$-.22M	$-1.77M
PE Ratio